Home / Insurance / Does Tricare Cover Semaglutide? Insurance Guide 20...
MC
Reviewed by Marcus Chen Updated February 20, 2026

Does Tricare Cover Semaglutide? Insurance Guide 2026

Semaglutide has transformed diabetes and obesity management, but navigating insurance coverage—especially with Tricare—can be complex. As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide is FDA-approved for type 2 diabetes (Ozempic®) and chronic weight management (Wegovy®). However, Tricare’s coverage policies for semaglutide vary based on indication, formulary status, and prior authorization requirements. This guide breaks down Tricare’s 2026 policies, costs, and appeal strategies to help beneficiaries access semaglutide efficiently.

Does Tricare Cover Semaglutide for Diabetes?

Tricare does cover semaglutide (Ozempic®) for type 2 diabetes under its pharmacy benefit, but coverage is subject to specific criteria. As of 2026, semaglutide is listed on Tricare’s Uniform Formulary for diabetes management, meaning it is a preferred brand-name medication when prescribed appropriately. To qualify, beneficiaries must demonstrate failure or intolerance to first-line therapies like metformin or sulfonylureas. Tricare follows evidence-based guidelines from the American Diabetes Association (ADA), which recommend GLP-1 receptor agonists like semaglutide for patients with established cardiovascular disease or those at high risk of complications.

Coverage is typically approved for semaglutide doses of 0.25 mg, 0.5 mg, 1 mg, or 2 mg weekly, aligning with FDA-approved labeling. However, Tricare may deny coverage if documentation is insufficient, such as missing hemoglobin A1c (HbA1c) levels or prior therapy trials. For active-duty service members, semaglutide may require additional justification due to potential side effects like gastrointestinal distress, which could impact duty readiness.

Does Tricare Cover Semaglutide for Weight Loss?

Tricare’s coverage of semaglutide (Wegovy®) for chronic weight management is more restrictive than for diabetes. As of 2026, Tricare does not universally cover Wegovy® under its standard pharmacy benefit, classifying it as a non-formulary medication for obesity. However, exceptions exist for beneficiaries who meet strict medical necessity criteria. To qualify, patients must have a body mass index (BMI) ≥ 30 kg/m² or ≥ 27 kg/m² with at least one weight-related comorbidity (e.g., hypertension, dyslipidemia, or obstructive sleep apnea). Additionally, they must have failed prior lifestyle interventions, such as diet and exercise, documented over at least 6 months.

Even if criteria are met, Tricare requires prior authorization for semaglutide, and approval is not guaranteed. The process often involves submitting clinical notes, BMI records, and evidence of prior weight-loss attempts. For active-duty members, coverage is further limited due to concerns about long-term dependency and side effects. Veterans using VA benefits may have slightly different criteria, as the VA has historically been more lenient with obesity medications.

How Much Does Semaglutide Cost With Tricare?

The cost of semaglutide with Tricare depends on the beneficiary’s status (active-duty, retiree, or dependent), formulary tier, and pharmacy network. For diabetes (Ozempic®), semaglutide is covered under Tricare’s Tier 3 (preferred brand-name) category, resulting in a copay of $29–$60 per 30-day supply for most beneficiaries. Retirees and their families pay the higher end of this range, while active-duty members typically pay $0–$11, depending on the pharmacy (military vs. retail).

For weight loss (Wegovy®), costs are significantly higher if not covered. Without prior authorization approval, beneficiaries may face the full cash price of $1,300–$1,600 per month. Even with approval, Tricare may impose quantity limits (e.g., 4 pens per 30 days) or require step therapy, where patients must try less expensive alternatives first. Using Tricare’s mail-order pharmacy (Express Scripts) can reduce out-of-pocket costs, as copays are often lower than at retail pharmacies.

For those struggling with affordability, manufacturer coupons (e.g., NovoCare®) may offer savings, but these are not combinable with Tricare. Beneficiaries should verify costs using Tricare’s online formulary tool or contact Express Scripts directly.

Semaglutide Prior Authorization for Tricare

Tricare requires prior authorization (PA) for semaglutide in all cases, whether for diabetes or weight loss. The PA process ensures the medication is medically necessary and aligns with Tricare’s clinical guidelines. For diabetes, providers must submit documentation showing:

  • Diagnosis of type 2 diabetes (ICD-10 code E11.x).
  • Failure or intolerance to at least one first-line oral antidiabetic (e.g., metformin).
  • Recent HbA1c levels (typically > 7.0% despite treatment).
  • Prescribed dose (must match FDA-approved ranges).

For weight loss, the requirements are stricter. Providers must include:

  • BMI ≥ 30 or ≥ 27 with comorbidity (e.g., hypertension, sleep apnea).
  • Documented failure of lifestyle interventions (e.g., dietitian notes, exercise logs).
  • Exclusion of secondary causes of obesity (e.g., hypothyroidism, Cushing’s syndrome).
  • Plan for ongoing monitoring (e.g., quarterly weight checks).

PA requests are submitted electronically via the Tricare Pharmacy Benefit Manager (Express Scripts). Approval typically takes 3–5 business days, but denials can occur if documentation is incomplete. If denied, providers can resubmit with additional justification or initiate an appeal.

How to Get Tricare to Cover Semaglutide

Securing Tricare coverage for semaglutide requires a proactive, evidence-based approach. Here’s a step-by-step strategy:

  1. Consult a Tricare-Authorized Provider: Only prescriptions from Tricare-credentialed providers (e.g., primary care, endocrinologists) are eligible. Active-duty members may need a referral from their Primary Care Manager (PCM).

  2. Gather Clinical Documentation:

    • For diabetes: HbA1c levels, prior medication trials, and cardiovascular risk factors.
    • For weight loss: BMI records, comorbidity diagnoses, and proof of failed lifestyle interventions.

  3. Submit Prior Authorization Early: Work with your provider to submit the PA before filling the prescription. Delays in submission can lead to out-of-pocket costs.

  4. Use Tricare’s Preferred Pharmacy Network: Fill prescriptions at military pharmacies (free) or Express Scripts mail-order (lowest copay). Retail pharmacies (e.g., CVS, Walgreens) may charge higher copays.

  5. Appeal if Denied: If Tricare denies coverage, request a peer-to-peer review with your provider or submit a formal appeal with additional evidence (e.g., letters of medical necessity).

  6. Explore Patient Assistance Programs: If coverage is denied, Novo Nordisk’s NovoCare® program offers savings cards for eligible patients, though these cannot be combined with Tricare.

What to Do If Tricare Denies Semaglutide

If Tricare denies coverage for semaglutide, beneficiaries have multiple appeal options. The first step is to request a reconsideration by submitting additional clinical evidence. For example:

  • Diabetes denials: Provide recent HbA1c trends, records of hypoglycemic events, or intolerance to alternative medications (e.g., GLP-1 side effects with liraglutide).
  • Weight loss denials: Include dietitian notes, exercise logs, or sleep study results (for sleep apnea).

If the reconsideration fails, beneficiaries can escalate to a formal appeal through Tricare’s appeals process. This involves:

  1. Submitting a written appeal within 90 days of the denial.
  2. Including a letter of medical necessity from the provider, detailing why semaglutide is the only viable option.
  3. Requesting an independent review by a Tricare-contracted physician if the appeal is denied again.

For urgent cases, beneficiaries can request an expedited appeal, which Tricare must resolve within 72 hours. Legal assistance from Tricare-approved advocates (e.g., through the Military Officers Association of America) may also help navigate complex denials.

Tricare Alternatives If Semaglutide Is Not Covered

If Tricare denies semaglutide or coverage is cost-prohibitive, several alternatives exist:

  1. Other GLP-1 Receptor Agonists:

    • Liraglutide (Victoza®/Saxenda®): Covered by Tricare for diabetes (Victoza®) and weight loss (Saxenda®) with prior authorization. Saxenda® has similar efficacy to Wegovy® but requires daily injections.
    • Dulaglutide (Trulicity®): Covered for diabetes; less effective for weight loss but may be a lower-cost option.
    • Exenatide (Byetta®/Bydureon®): Older GLP-1 agonists with Tricare coverage but higher side-effect profiles.

  2. Non-GLP-1 Medications:

    • Metformin: First-line for diabetes, fully covered, but minimal weight-loss benefits.
    • SGLT2 Inhibitors (e.g., empagliflozin): Covered for diabetes and may aid weight loss; lower cost but risk of urinary tract infections.
    • Phentermine/Topiramate (Qsymia®): Covered for weight loss with prior authorization; effective but has stimulant-like side effects.

  3. Lifestyle Interventions:

    • Tricare’s MOVE! Program: Free weight-management program for beneficiaries, including nutrition counseling and exercise plans.
    • Dietitian Services: Covered under Tricare’s preventive services for obesity management.

  4. Clinical Trials: Some beneficiaries may qualify for free semaglutide through clinical trials (e.g., via ClinicalTrials.gov).

Frequently Asked Questions

Does Tricare cover Semaglutide for weight loss?

Tricare does not routinely cover semaglutide (Wegovy®) for weight loss, but exceptions exist for patients with BMI ≥ 30 or ≥ 27 with comorbidities who have failed lifestyle interventions. Prior authorization is required, and approval is not guaranteed. Active-duty members face additional restrictions due to duty-related concerns.

How much is the Semaglutide copay with Tricare?

For diabetes (Ozempic®), copays range from $0–$60 per month, depending on beneficiary status and pharmacy type. For weight loss (Wegovy®), the cost is $1,300–$1,600 per month without coverage. Using Tricare’s mail-order pharmacy can reduce out-of-pocket expenses.

Can I appeal if Tricare denies Semaglutide?

Yes, beneficiaries can appeal denials by submitting additional clinical evidence (e.g., HbA1c trends, dietitian notes) or requesting a peer-to-peer review with their provider. Formal appeals must be filed within 90 days of the denial, and expedited reviews are available for urgent cases.

Disclaimer from Marcus Chen, PharmD: The information in this article is based on Tricare’s 2026 policies and clinical guidelines. Coverage criteria may change, and individual cases may vary. Always consult your Tricare provider or Express Scripts for personalized guidance. This article is for informational purposes only and does not constitute medical or legal advice.